Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism. (PADIS-HTP)

R

Regional University Hospital Center (CHRU)

Status

Terminated

Conditions

HTPPE
Idiopathic Pulmonary Embolism

Treatments

Other: HTPPE

Study type

Interventional

Funder types

Other

Identifiers

NCT01894204
RB 12.161 - PADIS HTP

Details and patient eligibility

About

Forward-looking troop established(constituted) by the patients having been included in the study " PADIS EP ", PHRC on 2006 and 2009, randomized checked(controlled), double-blind, comparing an anticoagulating treatment(processing) extended by coumadine versus placebo during 18 months at patients having had a first episode of EP idiopathique treated(handled) initially 6 months by anti-vitamin K.

Enrollment

235 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients having ended the study PADIS EP after the visit of the end of study and having signed the consent HTP.

Exclusion criteria

Refusal to grant in writing to participate in the study PADIS HTP

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

235 participants in 1 patient group

HTPPE
Other group
Description:
No drug and no placebo were used in this study. For all the patients who participated at the study PADIS-EP, somme exams must be performed.
Treatment:
Other: HTPPE

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems